Lpl Financial LLC Genmab A/S Transaction History

Lpl Financial LLC

$218 Billion
Q3 2024

A detailed history of Lpl Financial LLC transactions in Genmab A/S stock. As of the latest transaction made, Lpl Financial LLC holds 189,148 shares of GMAB stock, worth $3.81 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

189,148

Previous 146,030 29.53%

Holding current value

$3.81 Million

Previous $3.67 Million 25.67%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	BUY	$23.84 - $28.48 $1.03 Million - $1.23 Million	43,118 Added 29.53%	189,148 $4.61 Million
Q2 2024 Aug 07, 2024	BUY	$25.13 - $30.27 $352,825 - $424,990	14,040 Added 10.64%	146,030 $3.67 Million
Q1 2024 May 10, 2024	BUY	$26.43 - $32.77 $1.26 Million - $1.57 Million	47,830 Added 56.83%	131,990 $3.95 Million
Q4 2023 Feb 14, 2024	BUY	$27.94 - $35.44 $620,882 - $787,547	22,222 Added 35.88%	84,160 $2.68 Million
Q3 2023 Nov 13, 2023	BUY	$35.27 - $42.24 $471,348 - $564,495	13,364 Added 27.51%	61,938 $2.18 Million
Q2 2023 Jul 31, 2023	BUY	$37.4 - $42.94 $41,401 - $47,534	1,107 Added 2.33%	48,574 $1.85 Million
Q1 2023 May 10, 2023	SELL	$34.88 - $43.22 $639,594 - $792,525	-18,337 Reduced 27.87%	47,467 $1.79 Million
Q4 2022 Feb 07, 2023	BUY	$33.8 - $47.06 $214,900 - $299,207	6,358 Added 10.7%	65,804 $2.79 Million
Q3 2022 Nov 14, 2022	BUY	$31.52 - $373.61 $541,702 - $6.42 Million	17,186 Added 40.67%	59,446 $1.91 Million
Q2 2022 Aug 12, 2022	BUY	$26.83 - $38.57 $54,947 - $78,991	2,048 Added 5.09%	42,260 $1.37 Million
Q1 2022 May 16, 2022	SELL	$30.95 - $39.68 $492,197 - $631,031	-15,903 Reduced 28.34%	40,212 $1.46 Million
Q4 2021 Feb 14, 2022	BUY	$35.87 - $47.12 $175,583 - $230,652	4,895 Added 9.56%	56,115 $2.22 Million
Q3 2021 Nov 15, 2021	BUY	$41.55 - $48.72 $187,889 - $220,311	4,522 Added 9.68%	51,220 $2.24 Million
Q2 2021 Aug 13, 2021	SELL	$32.88 - $44.57 $1.2 Million - $1.63 Million	-36,573 Reduced 43.92%	46,698 $1.91 Million
Q1 2021 May 14, 2021	BUY	$30.92 - $44.4 $626,933 - $900,254	20,276 Added 32.19%	83,271 $2.73 Million
Q4 2020 Feb 12, 2021	BUY	$33.66 - $40.76 $502,341 - $608,302	14,924 Added 31.05%	62,995 $2.56 Million
Q3 2020 Nov 09, 2020	BUY	$33.07 - $38.68 $1.07 Million - $1.25 Million	32,250 Added 203.84%	48,071 $1.76 Million
Q2 2020 Aug 13, 2020	BUY	$20.05 - $33.89 $317,211 - $536,173	15,821 New	15,821 $536,000

Others Institutions Holding GMAB

# of Institutions

238

Shares Held

52.6M

Call Options Held

10.2K

Put Options Held

25.5K

View Full List

About GENMAB A/S

Ticker GMAB
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 658,292,992
Market Cap $13.3B
Description
Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; ofatumurnab, a human monoclonal antibody to treat chronic lymphoc...

More about GMAB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lpl Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lpl Financial LLC with notifications on news.

Account

Lpl Financial LLC Genmab A/S Transaction History